United Kingdom - English - myHealthbox

bayer ag -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hyaluronidase, quantity: 1500 iu - injection, powder for - excipient ingredients: sodium hydroxide - hypodermoclysis. obstetrics anaesthesia. prevention of postpartum haemorrhage (with ergometrine). as an aid to local anaesthesia in ophthalmology. as an aid to local anaesthesia in fracture reduction. subcutaneous administration of radiopaque substances in pyelography.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - water for injections, quantity: 10 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - water for injections, quantity: 5 ml - injection, solution - excipient ingredients: - water for injections is used to dissolve or dilute substances or preparations for parenteral administration. water for injections may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 5 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 10 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mannitol, quantity: 100 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mannitol, quantity: 200 g/l - injection, solution - excipient ingredients: hydrochloric acid; sodium hydroxide; water for injections - osmitrol intravenous infusion (mannitol intravenous infusion, bp) can be used in: the promotion of diuresis in the prevention and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established; the reduction of intraocular pressure when the pressure cannot be lowered by other means; the reduction of intracranial pressure and treatment of cerebral oedema by reducing brain mass and; promoting the urinary excretion of toxic substances.